Evidence map›Paper›PMID 42490064›Full record

ArticleJournal of chemical information and modeling2026

In Silico Isomerization Produces Apt Negative Data for VHTS Validation.

Stefan M Ivanov

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Stefan M IvanovFaculty of Pharmacy, Medical University of Sofia, Dunav 2 Str., Sofia1000, Bulgaria.ORCID 0000-0002-6949-2328

Funding

NextGenerationEU BG16RFPR002-1.014-0018-C01/2025NextGenerationEU BG-RRP-2.004-0004-C01
6 · The paper itself

Abstract

Early on in the emergence of virtual high-throughput screening (VHTS), it was recognized that, for validation to be robust and reliable, decoys should match actives as closely as possible in as many aspects as possible. This has given rise to several generations of validation sets that address previously reported shortcomings of earlier collections. This is an iterative and expensive method of curating validation sets that leaves ample scope for discrepancies between actives and decoys to creep in. It has previously been conjectured that in silico isomerization offers an attractive alternative for generating decoys for drug-like compounds that naturally mitigates many of these discrepancies. Here, we explore this proposition and prove the conjecture. We show that isomerization can produce molecules that have hydrogen bond acceptor, donor, rotatable bonds counts, charge, and surface area distributions that match experimental actives more closely than experimental decoys. While these are properties that receive a lot of attention in drug design, we also show that isomerization can effectively produce decoys that are positioned more closely to actives in property hyperspace than current experimental decoys, which tend to be highly dissimilar from the actives. The latter is a significant shortcoming that has thus far remained unreported and unaddressed. Additionally, we introduce the concept of pseudoisomers - decoys that have nearly identical atomic compositions to the actives - and show how they too can be used in VHTS validation at practically no cost. Herein, we build upon the methods, tools, and work of others to facilitate the generation of new and better validation sets more cheaply and efficiently, in the hope of moving the field of VHTS forward toward maturity. To that end, we make our code fully and freely available on GitHub (https://github.com/sivanovMU-Sofia/isomerization).

Indexed as

Computer SimulationHigh-Throughput Screening AssaysHydrogen BondingIsomerism

Identifiers

PMID42490064
PMCPMC13471428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.